Factors associated with hyperglycemia and low insulin levels in children undergoing cardiac surgery with cardiopulmonary bypass who received a single high dose of methylprednisolone

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.68, n.1, p.85-92, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: Administering steroids before cardiopulmonary bypass in pediatric heart surgery modulates systemic inflammatory response syndrome and improves postoperative recovery. However, the use of steroids aggravates hyperglycemia, which is associated with a poor prognosis. Adult patients with systemic inflammatory response syndrome usually evolve with hyperglycemia and high insulin levels, whereas >90% of pediatric patients exhibit hyperglycemia and low insulin levels. This study aims to determine: A) the metabolic and inflammatory factors that are associated with hyperglycemia and low insulin levels in children who underwent cardiac surgery with cardiopulmonary bypass and who received a single high dose of methylprednisolone and B) the best predictors of insulin variation using a mathematical model. METHODS: This preliminary study recruited 20 children who underwent heart surgery with cardiopulmonary bypass and received methylprednisolone (30 mg/kg) immediately after anesthesia. Among the 20 patients initially recruited, one was excluded because of the absence of hyperglycemia and lower insulin levels after surgery. However, these abnormalities were confirmed in the remaining 19 children. The C-peptide, CRP, IL-6, and adrenomedullin levels were measured before surgery, immediately after cardiopulmonary bypass, and on the first, second, and third days after cardiac surgery. RESULTS: IL-6, CRP, and adrenomedullin increments were observed, whereas the C-peptide levels remained within reference intervals. CONCLUSION: The multiple regression model demonstrated that in addition to age and glycemia (two well-known factors that are directly involved in glucose metabolism), adrenomedullin and IL-6 levels were independent factors associated with lower insulin concentrations. These four parameters were responsible for 64.7% of the observed insulin variances. In addition, the fact that C-peptide levels did not fall together with insulin could have grounded the medical decision not to administer insulin to patients.
Palavras-chave
Cardiopulmonary Bypass, Adrenomedullin, Insulin, Hyperglycemia, Systemic Inflammatory Response Syndrome
Referências
  1. Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044
  2. Bialkowski J, 1997, REV ESP CARDIOL, V50, P782
  3. BLAND JM, 1986, LANCET, V1, P307
  4. Cheung BMY, 2011, EUR J ENDOCRINOL, V165, P571, DOI 10.1530/EJE-11-0513
  5. Clarizia NA, 2011, ANN THORAC SURG, V91, P1222, DOI 10.1016/j.athoracsur.2010.11.005
  6. Dhar A, 2011, CURR OPIN PEDIATR, V23, P269, DOI 10.1097/MOP.0b013e3283464b3e
  7. FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173
  8. Van Herpe Tom, 2011, J Diabetes Sci Technol, V5, P353
  9. Knapik P, 2009, ANN THORAC SURG, V87, P1859, DOI 10.1016/j.athoracsur.2009.02.066
  10. Komai H, 1998, PERFUSION-UK, V13, P334, DOI 10.1177/026765919801300509
  11. KONG AN, 1990, PHARMACOTHERAPY, V10, P29
  12. Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626
  13. Moga MA, 2011, CRIT CARE MED, V39, P266, DOI 10.1097/CCM.0b013e3181fee88e
  14. Nagata N, 1997, ANESTH ANALG, V84, P1193, DOI 10.1097/00000539-199706000-00004
  15. Oberhoffer M, 1999, CRIT CARE MED, V27, P1814, DOI 10.1097/00003246-199909000-00018
  16. Preissig CM, 2008, PEDIATR CRIT CARE ME, V9, P581, DOI 10.1097/PCC.0b013e31818d36cb
  17. Rapp-Kesek D, 2007, SCAND CARDIOVASC J, V41, P102, DOI 10.1080/14017430601050355
  18. Royston JP, 1983, J ROYAL STAT SOC D, V32, P297
  19. Rubens FD, 2005, ANN THORAC SURG, V79, P655, DOI 10.1016/j.athoracsur.2004.07.044
  20. Scohy TV, 2011, PEDIATR ANESTH, V21, P872, DOI 10.1111/j.1460-9592.2011.03571.x
  21. Sekine N, 2006, AM J PHYSIOL-ENDOC M, V291, pE9, DOI 10.1152/ajpendo.00213.2005
  22. Brealey David, 2009, J Diabetes Sci Technol, V3, P1250
  23. Urban K, 2007, PERFUSION-UK, V22, P207, DOI 10.1177/0267659107081632
  24. VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368
  25. Van den Berghe G, 2011, J CLIN ENDOCR METAB, V96, P1272, DOI 10.1210/jc.2011-0683
  26. Verhoeven JJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10006
  27. Verhoeven JJ, 2011, PEDIATR CARDIOL, V32, P131, DOI 10.1007/s00246-010-9829-z
  28. Vigneswaran VT, 1989, PERFUSION, V4, P33
  29. Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1